momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (3233)	9/27/2005 10:25:24 PM
From: rkrw	Read Replies (2) of 12215

Coincidentally I spent the morning with my father at his liver tx unit. Talked hcv therapies with his doc. vx 950 cuts down on treatment time to 1-3 months as Boger is now claiming might be possible (I have a hard time fully trusting him/this), it will blow the lid off the hcv market. Treatments are so taxing now they take a wait and see approach on recommending treatment, but if treatment time were 3 months with better outcomes I expect they'd recommend to virtually all their patients. 950 is a legit breakthrough bio drug opp.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next